new glp-1 retatrutide drug Treatment with retatrutide, an agonist to GLP-1, GIP, and glucagon Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide
Description
Some people see significant changes in the first month
Horm Metab Res (2021) 53(6):4027
Regulatory restrictions on compounded GLP-1 drugs limit unapproved alternatives, strengthening demand for branded products
They do not like being overstimulated
Pedersen: Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice
If hypoglycaemia is recurrent, the prescribing clinician may need to adjust doses of concomitant glucose-lowering medications
